The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 330:862-863 March 24, 1994 Number 12
NextNext

Low-Molecular-Weight Heparin vs. Warfarin for Prophylaxis against Deep-Vein Thrombosis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Hull, R.
To the Editor: Hull and colleagues (Nov. 4 issue)1 compared postoperative warfarin therapy with a once-daily postoperative regimen of the low-molecular-weight heparin Logiparin for the prevention of postoperative venous thrombosis in patients undergoing major orthopedic surgery. They found a small but significant reduction in thrombosis in the low-molecular-weight-heparin group at the cost of a small but significant increase in bleeding. The event rate in the low-molecular-weight-heparin group was higher than that reported in other studies that used a twice-daily postoperative dosing regimen and mandatory venography to assess thrombosis2,3,4,5. The observed differences in the incidence of postoperative thrombosis between the . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.